Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 12, 2016 4:46 PM ET

Capital Markets

Company Overview of Accelerator Corporation

Company Overview

Accelerator Corporation is a venture capital firm specializing in incubation, early stage, emerging growth and start-up investments. It does not participate in further rounds of financing. The firm prefers to invest in life sciences, biotechnology, and new therapeutics companies. It typically invests in New York City and Seattle. It seeks to invest up to $2 million in a company. The firm typically holds its investments for a period between 12 months and 24 months. Accelerator Corporation was founded in 2003 and is based in Seattle, Washington with an additional office in New York City, New York.

1616 Eastlake Avenue East

Suite 200

Seattle, WA 98102

United States

Founded in 2003





Key Executives for Accelerator Corporation

Chief Executive Officer and Director
Age: 41
Founding Institution Partner and Director
Age: 76
Chief Financial Officer
Chief Operating Officer
Age: 49
Director of Operations
Compensation as of Fiscal Year 2015.

Accelerator Corporation Key Developments

Accelerator Corporation Appoints David Pompliano as Interim Chief Scientific Officer

Accelerator Corporation announced the formation of Lodo Therapeutics Corporation to develop novel therapeutics derived from the company's metagenomics-based small molecule discovery platform. Veteran drug hunter and Lodo Therapeutics co-founder David Pompliano, Ph.D., will join the company as interim chief scientific officer. Dr. Pompliano is a well-established and internationally known scientist with extensive experience in the discovery and early development of anti-infective and oncology drugs within both large pharmaceutical companies and small biotechnology firms.

Accelerator Corporation Presents at NewYork BIO 25th Anniversary Conference 2015, May-04-2015 01:50 PM

Accelerator Corporation Presents at NewYork BIO 25th Anniversary Conference 2015, May-04-2015 01:50 PM. Venue: Time Warner Center, New York, United States. Speakers: David M. Schubert, Chief Operating Officer.

Washington State University Enters into Strategic Partnership with Accelerator Corp

Washington State University has entered into a strategic partnership with Accelerator Corp., becoming one of eight new Northwest institutional partners in the company's $51.1 million venture. This partnership adds value to University efforts to commercialize WSU faculty-driven innovations in the marketplace.

Similar Private Companies By Industry

Company Name Region
W.A.B. Capital, LLC United States
Asgaard Capital LLC United States
Development Specialists, Inc., Investment Banking Arm United States
Kern, Suslow Securities, Inc. United States
Goldner Venture Partners Investment Arm-Demo United States

Recent Private Companies Transactions

Private Placement
January 6, 2016
Petra Pharma Corporation
Private Placement
December 21, 2015
Lodo Therapeutics Corp.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Accelerator Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at